DONATE

ICREA Academia Award for IBEC group leader

SONY DSCGabriel Gomila, IBEC group leader and Associate Professor at the UB, has received an ICREA Academia Prize 2014 for excellence in research and capacity for leadership.

Bestowed annually by the Catalan Institution for Research and Advanced Studies (ICREA) to encourage university professionals with an outstanding research career to stay in the Catalan university system, this year’s list of 30 winners is made up of 10 researchers from the UB, 8 from the UAB, 6 from the UPC, 3 from the UPF, 2 from Universitat de Girona and one from the Universitat Rovira i Virgili.

Josep Samitier elected new president of ACER

acerboardLast week, IBEC Director Josep Samitier was named new president of the Associació Catalana d’Entitats de Recerca (ACER).

Josep takes the reins from IFCO director Lluís Torner, who has held the position since 2009. The association’s first President was the Hon. Mr. Andreu Mas-Colell. The other members of the Director’s Board are ICAC’s Joan Gómez Pallarès (Secretary), Ramon Gomis (IDIBAPS), Jordi Galí (CREI) and Josep M. Monfort (IRTA) as members.

“Mini-kidney” scientist joins IBEC with ERC grant

nmontserratA new group leader at IBEC brings one of the most prestigious funding awards, an ERC Starting Grant, to continue her research into kidney regeneration

Nuria Montserrat (Barcelona, 1978) is one of just eight young researchers in Catalonia to have received a prestigious European Research Council (ERC) Starting Grant at the end of 2014.

Wounds heal using a cellular ‘tug-of-war’

Researchers at IBEC reveal in a Nature Communications paper some surprising mechanics that drive epithelial gap closure in the absence of underlying layers

In a collaboration with their colleagues at the Mechanobiology Institute in Singapore, IBEC researchers have demonstrated that a kind of ‘tug-of-war’ takes place after our skin or other epithelial layer is damaged, particularly in cases where the tissue is chronicly or deeply injured.

A further step towards light-controlled drugs

MVI_4165_Researchers in Barcelona discover more potential candidates on the route to tailored, photo-switchable therapies by disproving design limitation

Last year, scientists at the Institute for Bioengineering of Catalonia (IBEC), IRB Barcelona and the UB announced that they had achieved photo-switchable, or light-regulated, molecules to control protein-protein interactions – key determinants in biological processes, and therefore highly promising therapeutic targets – in a remote and non-invasive way.

Key player identified in bacterial infections

torrentsjanA group at IBEC has identified a important factor in E. coli infection, opening the way to developing targeted drugs against the potentially deadly condition.

Most E. coli bacterial strains occur naturally in the human gut and pose no harm to health, except for the one particular serotype that always hits the news, O157:H7, which can cause food poisoning and can become life-threatening in certain patients.

Virtualising patients’ spines for better decision-making on back treatments

myspine2015– The EU-funded MySpine project completes its goal of developing prognosis technology for spinal problems

– Consortium now looking for a transfer opportunity to bring its technology into the healthcare system

Even though lower back pain and spinal disorders are the leading cause of disability in western countries, their treatment still leaves a lot to be desired.

New IBEC group leader a top name in nanomotors

SONY DSCOne of the world’s top researchers – and a record-breaker – in the field of nano- and microrobots is coming to Barcelona to continue his career.

The Institute for Bioengineering of Catalonia (IBEC) welcomes Dr. Samuel Sánchez (Terrassa, 1980), who is taking up a new Group Leader position there this month. He’ll be continuing his work on tiny self-propelling machines that not so long ago were still only fantasy – such as the miniature submarine Proteus, injected into a scientist’s bloodstream in the film Fantastic Voyage – and which are now becoming very much a reality.